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Abstract  
OBJECTIVES: To investigate the effect of meal intake on liver stiffness measurement (LSM) and 
controlled attenuation parameter (CAP) in patients with biopsy-proven nonalcoholic fatty liver disease 
undergoing vibration-controlled transient elastography.  
METHODS: LSM and CAP were assessed at baseline and serially for 6 hours after meal intake in 24 
patients.  
RESULTS: A significant increase in LSM was seen up to the 2-hour time point (26 +/- 25%, P = 0.02). The 
CAP scores changed minimally with a maximal change of 3% (P > 0.1).  







Staging of liver fibrosis by liver biopsy is integral to the evaluation and management of nonalcoholic 
fatty liver disease (NAFLD) (1). Because of the invasive nature of the biopsy, vibration-controlled 
transient elastography (VCTE) is widely in use owing to its ability to noninvasively assess liver fibrosis 
with liver stiffness measurement (LSM) and steatosis with controlled attenuation parameter (CAP) (2-
4).  
Previous studies using a medium (M+) probe and a meal challenge with commercial formulas in healthy 
subjects and patients with viral hepatitis showed a peak increase in LSM at 60 minutes with values 
returning to baseline within 120 minutes (5-7). The effect of meal intake on CAP scores is currently not 
well understood because 1 study (5) reported an increase, whereas the other, a decrease (8). The 
objectives of this study were to systematically investigate the impact of meal intake and its time course 
on LSM and CAP in individuals with and without advanced fibrosis from NAFLD. To examine the 
relationship between the calorie content and the change in LSM/CAP, the meal challenge allowed for 
unrestricted consumption of food from the hospital cafeteria.  
 
MATERIALS AND METHODS  
Study population  
The effect of food intake on LSM and CAP was assessed in 24 patients with biopsy-proven NAFLD (12 
with advanced fibrosis (stages 3 and 4) and 12 without advanced fibrosis (<=stage 2)). To assess the 
variability of LSM and CAP with time, 8 of the study participants were randomly selected to serve as 
unfed controls and underwent LSM and CAP measurements on a subsequent day, but in the fasting 
state. The Indiana University Institutional Review Board approved the study. All subjects provided 
written informed consent before participating in the current study.  
Determination of LSM and CAP by VCTE  
An expert operator obtained baseline measurements of LSM and CAP 5 minutes apart (the average 
served as the baseline) using FibroScan 502 Touch (Echosens, France) after an overnight fast. When 10 
valid measurements with interquartile (IQR)/median ratio of <30% were obtained, the site was marked 
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with a pen for subsequent measurements of LSM/CAP. A registered dietician calculated the calorie, fat, 
carbohydrate, and protein content of the meal using the MyFitnessPal app 
(https://www.myfitnesspal.com/). The patients returned for the postprandial measurement of 
LSM/CAP at 30 minutes, 1, 2, 3, 4, 5, and 6 hours after completion of the meal.  
Statistical analysis  
For descriptive analysis, continuous variables were expressed as mean +/- s.d. and categorical variables 
as frequency (%). The multivariable mixed model approach was used to analyze the effect of a meal on 
LSM and CAP at each time point compared with the baseline (or premeal values). P < 0.05 was taken as 
statistical significance. Stata software version 14 and SAS v9.4 (SAS Institute, Cary, NC) were used to 
perform the statistical analyses.  
RESULTS  
The mean age of the study cohort was 50 +/- 11 years (54% females; body mass index (BMI): 38 +/- 6 
kg/m2) with a mean alanine aminotransferase of 47 +/- 21 U/L. Seventeen of the 24 subjects underwent 
VCTE with the extra-large (XL+) probe. All scans were valid (10 values) and reliable with IQR/median 
<30%. The median LSM was 9.6 kPa (95% confidence interval: 8.0-14.9 kPa). The median CAP score was 
343 dB/m (95% confidence interval: 323-361 dB/m). The study participants consumed a mean of 894 
+/- 330 kcal in 18 +/- 7 minutes.  
Effect of meal intake on LSM  
The increase in the LSM was seen up to the 2-hour time point with a mean increase of 1.6 +/- 3.8 
kPa (26% +/- 25%) (P = 0.02). The mean increase in LSM at 3, 4, 5, and 6 hours was less than 1.2 kPa 
(10%). The increase in LSM was seen in both early (1.34 +/- 1.85 kPa or 31% +/- 29%) and advanced 
fibrosis groups (2.0 +/- 5.3 kPa or 21% +/- 21%), and reached statistical significance (P = 0.027) 
(Figure 1). Compared with the unfed state, LSM was significantly increased at 30 minutes (P = 
0.0024), 1 (P = 0.0013), and 2 h (P <= 0.0001) with a maximal % increase of 26% +/- 19% (Figure 2). 
This difference remained significant even after adjusting for age, sex, and BMI. Subjects who 
underwent VCTE using M+ probe did not differ from those who underwent study with XL + probe in 
either the absolute (2 +/- 4.5 vs 0.7 +/- 1.4 kPa, P = 0.1) or the relative increase in LSM (28 +/- 27 vs 
20% +/- 20%, P = 0.4) at the 2-hour time point.  




The maximal increase in the LSM in the initial 2 hours was significantly correlated with the number of 
calories in the meal in the entire group (r = 0.4, P = 0.03). We then examined the relationship between 
meal contents in individuals (n = 8) who developed >= 2 kPa (arbitrary but clinically meaningful) 
increase in LSM at the 2-hour time point. These individuals consumed significantly higher protein (42 
+/- 10 vs 31 +/- 10 g, P = 0.019), but not fat (45 +/- 14 vs 38 +/- 15 g, P = 0.2) or carbohydrates (125 +/- 
65 vs 84 +/- 37 g, P = 0.1).  
Effect of food intake on CAP  
In the fed state, the CAP score was numerically lower with a maximal change of -3% +/- 13% 
throughout the study and was not statistically significant from the baseline when adjusted for age, BMI, 
sex, and baseline CAP values. The absolute change at 2 hours after meal ingestion was -13 +/- 36 dB/m 
(P = 0.11).  
DISCUSSION  
In the current study, the maximal increase in LSM occurred at the 2-hour time point with a return to 
the values close to the baseline by 3 hours. This finding is in contrast to previously reported studies, 
implying that LSM values returned to baseline by 2 hours (6,7). The additional hour required for the 
return of LSM to near-baseline values is possibly because of the number of calories consumed, content 
of the meal, or underlying liver disease. The current study suggests that patients with NAFLD with early 
fibrosis are more susceptible to a meal-related increase in LSM. The increase in the LSM does not 
appear to be related to the probe size. Finally, the meal intake did not affect the CAP values in a 
significant way. In summary, at least 3 hours of fasting is necessary to minimize the false increase in 
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Percent change in LSM (kPa) as compared to baseline after meal challenge in patients with NAFLD with 
no/early fibrosis, i.e., F0-F2 (n = 12), and with advanced fibrosis, i.e., F3-F4 (n = 12). At baseline, the 
median LSM in no/early fibrosis group was 6.9 kPa (95% CI: 6.0–9.9 kPa) and in advanced fibrosis group, 
was 11.8 kPa (95% CI: 8.6–21.5 kPa). CI, confidence interval; LSM, liver stiffness measurement, NAFLD, 






Percent change from baseline in LSM (%) with and without meal challenge during the study period, 0–6 
hours (n = 8). Each participant underwent LSM/CAP measurement with and without meal challenge on 
different days. CAP, controlled attenuation parameter; LSM, liver stiffness measurement. 
 
